A carregar...
Btk Inhibitors: A Medicinal Chemistry and Drug Delivery Perspective
In the past few years, Bruton’s tyrosine Kinase (Btk) has emerged as new target in medicinal chemistry. Since approval of ibrutinib in 2013 for treatment of different hematological cancers (as leukemias and lymphomas), two other irreversible Btk inhibitors have been launched on the market. In the at...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8303217/ https://ncbi.nlm.nih.gov/pubmed/34299259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22147641 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|